TY  - JOUR 
AU  - Montes Martínez, Ariadna
AU  - Pérez Pampín, Eva
AU  - Narváez, Javier
AU  - Cañete, Juan D
AU  - Navarro-Sarabia, Federico
AU  - Moreira, Virginia
AU  - Fernández Nebro, Antonio
AU  - Ordóñez, María del Carmen
AU  - De la Serna, Arturo R
AU  - Magallares, Berta
AU  - Vasilopoulos, Yiannis
AU  - Sarafidou, Theologia
AU  - Caliz, Rafael
AU  - Ferrer, Miguel Angel
AU  - Joven, Beatriz
AU  - Carreira, Patricia
AU  - Gómez-Reino Carnota, Juan Jesús
AU  - González Martínez-Pedrayo, Antonio
PY  - 2014
SN  - 1744-6872
UR  - http://hdl.handle.net/20.500.11940/17704
AB  - [EN] Objectives: We aimed to assess a functional polymorphism in FCGR2A, H131R, for association with treatment response to Fc-containing inhibitors of TNF. Methods: A total of 429 biologic-naïve patients with rheumatoid arthritis (RA) collected in two...
LA  - eng
KW  - Tumor Necrosis Factor-alpha
KW  - Arthritis, Rheumatoid
KW  - Receptors, IgG
KW  - Genetic Association Studies
KW  - Rheumatology
KW  - Infliximab
KW  - Antibodies, Monoclonal
KW  - Etanercept
KW  - Spain
KW  - Arthritis
KW  - Adalimumab
TI  - Association of FCGR2A  with the response to infliximab treatment of patients with rheumatoid arthritis.
T2  - Pharmacogenetics and Genomics
M2  - 238
KW  - anti-TNF
KW  - Fc receptor
KW  - FCGR2A
KW  - IDIS
KW  - CHUS
VL  - 24
ER  -